Drug shows promise against Sudan strain of Ebola in mice
Researchers from Albert Einstein College of Medicine and other institutions have developed a potential antibody therapy for Sudan ebolavirus, a lethal strains of Ebola. A different strain, the Zaire ebolavirus, is now devastating West Africa. The findings were reported in ACS Chemical Biology. August 28, 2014